Donepezil, a cholinesterase inhibitor used in Alzheimer's disease therapy, is actively exported out of the brain by abcb1ab p-glycoproteins in mice.

MLA

Spieler, Derek, et al. “Donepezil, a Cholinesterase Inhibitor Used in Alzheimer’s Disease Therapy, Is Actively Exported out of the Brain by Abcb1ab p-Glycoproteins in Mice.” Journal of Psychiatric Research, vol. 124, May 2020, pp. 29–33. EBSCOhost, https://doi.org/10.1016/j.jpsychires.2020.01.012.

APA

Spieler, D., Namendorf, C., Namendorf, T., von Cube, M., & Uhr, M. (2020). Donepezil, a cholinesterase inhibitor used in Alzheimer’s disease therapy, is actively exported out of the brain by abcb1ab p-glycoproteins in mice. Journal of Psychiatric Research, 124, 29–33. https://doi.org/10.1016/j.jpsychires.2020.01.012

Chicago

Spieler, Derek, Christian Namendorf, Tamara Namendorf, Maja von Cube, and Manfred Uhr. 2020. “Donepezil, a Cholinesterase Inhibitor Used in Alzheimer’s Disease Therapy, Is Actively Exported out of the Brain by Abcb1ab p-Glycoproteins in Mice.” Journal of Psychiatric Research 124 (May): 29–33. doi:10.1016/j.jpsychires.2020.01.012.